Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report)’s share price traded down 3% during trading on Thursday . The stock traded as low as $0.48 and last traded at $0.48. 97,531 shares were traded during trading, a decline of 88% from the average session volume of 843,116 shares. The stock had previously closed at $0.50.
Azitra Price Performance
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.48) by $0.31. On average, research analysts forecast that Azitra, Inc. will post -2.78 earnings per share for the current year.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Read More
- Five stocks we like better than Azitra
- What is a Secondary Public Offering? What Investors Need to Know
- Fast-Growing Companies That Are Still Undervalued
- Why Invest in High-Yield Dividend Stocks?
- Top Cybersecurity Stock Picks for 2025
- How to Capture the Benefits of Dividend Increases
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
